Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bi-directional genetic modulation of GSK-3β exacerbates hippocampal neuropathology in experimental status epilepticus
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 10, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-20
DOI
10.1038/s41419-018-0963-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Alzheimer's Disease with the GSK-3 Inhibitor Tideglusib: A Pilot Study
- (2018) Teodoro del Ser et al. JOURNAL OF ALZHEIMERS DISEASE
- Neuroinflammatory targets and treatments for epilepsy validated in experimental models
- (2017) Eleonora Aronica et al. EPILEPSIA
- Spatiotemporal progression of ubiquitin-proteasome system inhibition after status epilepticus suggests protective adaptation against hippocampal injury
- (2017) Tobias Engel et al. Molecular Neurodegeneration
- Stressed and Inflamed, Can GSK3 Be Blamed?
- (2017) Richard S. Jope et al. TRENDS IN BIOCHEMICAL SCIENCES
- Deletion of the BH3-only protein Noxa alters electrographic seizures but does not protect against hippocampal damage after status epilepticus in mice
- (2017) Naoki Ichikawa et al. Cell Death & Disease
- Regulation of Inflammation and T Cells by Glycogen Synthase Kinase-3: Links to Mood Disorders
- (2017) Eleonore Beurel NEUROIMMUNOMODULATION
- RNA sequencing of synaptic and cytoplasmic Upf1-bound transcripts supports contribution of nonsense-mediated decay to epileptogenesis
- (2017) Claire M. Mooney et al. Scientific Reports
- Anticancer Mammalian Target of Rapamycin (mTOR) Signaling Pathway Inhibitors: Current Status, Challenges and Future Prospects in Management of Epilepsy
- (2016) Arindam Ghosh Mazumder et al. CNS & Neurological Disorders-Drug Targets
- Apoptosis through Death Receptors in Temporal Lobe Epilepsy-Associated Hippocampal Sclerosis
- (2016) Marcelo Ananias Teocchi et al. MEDIATORS OF INFLAMMATION
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- Infections, inflammation and epilepsy
- (2015) Annamaria Vezzani et al. ACTA NEUROPATHOLOGICA
- Excitotoxicity induced by kainic acid provokes glycogen synthase kinase-3 truncation in the hippocampus
- (2015) Jerónimo Jurado-Arjona et al. BRAIN RESEARCH
- Decreased glycogen synthase kinase-3 levels and activity contribute to Huntington's disease
- (2015) Marta Fernández-Nogales et al. HUMAN MOLECULAR GENETICS
- Interleukin-1β plays a role in the pathogenesis of mesial temporal lobe epilepsy through the PI3K/Akt/mTOR signaling pathway in hippocampal neurons
- (2015) Zhaohua Xiao et al. JOURNAL OF NEUROIMMUNOLOGY
- Epilepsy: new advances
- (2015) Solomon L Moshé et al. LANCET
- Status epilepticus in adults
- (2015) John P Betjemann et al. LANCET NEUROLOGY
- The Role of Wnt/β-Catenin Signaling Pathway in Disrupted Hippocampal Neurogenesis of Temporal Lobe Epilepsy: A Potential Therapeutic Target?
- (2015) Cheng Huang et al. NEUROCHEMICAL RESEARCH
- Mouse hippocampal phosphorylation footprint induced by generalized seizures: Focus on ERK, mTORC1 and Akt/GSK-3 pathways
- (2015) Giuseppe Gangarossa et al. NEUROSCIENCE
- Activation of AKT/GSK3β pathway by TDZD-8 attenuates kainic acid induced neurodegeneration but not seizures in mice
- (2015) Malay Bhowmik et al. NEUROTOXICOLOGY
- Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
- (2015) Eleonore Beurel et al. PHARMACOLOGY & THERAPEUTICS
- Caspase Functions in Cell Death and Disease: Figure 1.
- (2015) David R. McIlwain et al. Cold Spring Harbor Perspectives in Biology
- Histamine H3 receptor antagonism by ABT-239 attenuates kainic acid induced excitotoxicity in mice
- (2014) Malay Bhowmik et al. BRAIN RESEARCH
- Glycogen Synthase Kinase-3 as a Therapeutic Target for Cognitive Dysfunction in Neuropsychiatric Disorders
- (2014) Olivia O’Leary et al. CNS DRUGS
- Dynamic range of GSK3α not GSK3β is essential for bidirectional synaptic plasticity at hippocampal CA3-CA1 synapses
- (2014) Lion Shahab et al. HIPPOCAMPUS
- Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain
- (2014) N. K. H. Lim et al. HUMAN MOLECULAR GENETICS
- Mice Lacking Functional Fas Death Receptors Are Protected from Kainic Acid-Induced Apoptosis in the Hippocampus
- (2014) Miren Ettcheto et al. MOLECULAR NEUROBIOLOGY
- A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
- (2014) Eduardo Tolosa et al. MOVEMENT DISORDERS
- CHOP regulates the p53–MDM2 axis and is required for neuronal survival after seizures
- (2013) Tobias Engel et al. BRAIN
- Understanding the relationship between GSK-3 and Alzheimer’s disease: a focus on how GSK-3 can modulate synaptic plasticity processes
- (2013) Miguel Medina et al. Expert Review of Neurotherapeutics
- A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials
- (2013) Michael Wong Expert Review of Neurotherapeutics
- GSK-3β may be involved in hippocampal mossy fiber sprouting in the pentylenetetrazole-kindling model
- (2013) WEN-JIAO HUANG et al. Molecular Medicine Reports
- Neuronal Apoptosis and Motor Deficits in Mice with Genetic Inhibition of GSK-3 Are Fas-Dependent
- (2013) Raquel Gómez-Sintes et al. PLoS One
- Lovastatin Modulates Glycogen Synthase Kinase-3β Pathway and Inhibits Mossy Fiber Sprouting after Pilocarpine-Induced Status Epilepticus
- (2012) Chun-Yao Lee et al. PLoS One
- Wortmannin Reduces Insulin Signaling and Death in Seizure-Prone Pcmt1−/− Mice
- (2012) Kennen B. MacKay et al. PLoS One
- GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease
- (2012) Chong Gao et al. REVIEWS IN THE NEUROSCIENCES
- Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
- (2011) Juan Manuel Domínguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- In vivo Contributions of BH3-Only Proteins to Neuronal Death Following Seizures, Ischemia, and Traumatic Brain Injury
- (2011) Tobias Engel et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
- (2011) Hagit Eldar-Finkelman et al. Frontiers in Molecular Neuroscience
- NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy
- (2010) Raquel Gómez-Sintes et al. JOURNAL OF CLINICAL INVESTIGATION
- Reduced hippocampal damage and epileptic seizures after status epilepticus in mice lacking proapoptotic Puma
- (2009) Tobias Engel et al. FASEB JOURNAL
- GSK-3: A key player in neurodegeneration and memory
- (2009) Karl Peter Giese IUBMB LIFE
- Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice
- (2008) Genshin Mouri et al. BRAIN RESEARCH
- The Mood-Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase-3
- (2003) Guang Chen et al. JOURNAL OF NEUROCHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started